ClearPoint Neuro Inc vs Cassava Sciences Inc — how do they compare? ClearPoint Neuro Inc trades at $14.86 (market cap $454.21M), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: ClearPoint Neuro Inc is far larger — about 9.5× Cassava Sciences Inc's market cap, and ClearPoint Neuro Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| CLPT | FLNA | |
|---|---|---|
Market Cap | $454.21M | $47.75M |
Sector | Health | Health |
52-Week High | $29.60 | $4.64 |
52-Week Low | $8.66 | $0.87 |
Enterprise Value | $488.79M | -$34.93M |
Trailing returns across standard periods
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →